Expression of a 260kDa Neuroblastoma Surface Antigen, the Target of Cytotoxic Natural Human IgM: Correlation to MYCN Amplification and Effects of Retinoic Acid

By David K.   Ehrhardt A.   Ollert M.W.   Erttmann R.   Bredehorst R.   Vogel C.-W.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1937-1941

Elsevier

Access to resources Recommend Favorite

Unique dose-dependent effects of the human pregnancy hormone estriol on the ratio of blood IgM to IgG in female mice

By Ding Jian   Zhu BaoTing  

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 447-452

Spandidos Publications

Access to resources Recommend Favorite

Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review)

By          

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1106-1114

Spandidos Publications

Access to resources Recommend Favorite

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

By Irie Reiko   Ollila David   O’Day Steven   Morton Donald  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 2, 2004-02 ,pp. : 110-117

Springer Publishing Company

Access to resources Recommend Favorite

Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG

By        

Experimental and Therapeutic Medicine, Vol. 7, Iss. 4, 2014-01 ,pp. : 849-854

Spandidos Publications

Access to resources Recommend Favorite